Company

STH Biotech

4, rue Pierre Fontaine – Campus 3
91058 Evry-Courcouronnes Cedex – FRance
Email : h.mailhac@sth-biotech.com

CEO: Héloïse MAILHAC
CTO: Naomi KAMINSKY

Web Site >

Shaker #Industrial Biotech #Biomanufacturing

Plant-based biotechnologies
Active compounds
Cannabis
Pharmaceutics

Field of Activity

Via plant biotechnologies, STH BIOTECH reveals the potential of the active compounds of cannabis.

BACKGROUND
Founded by two engineers, both graduates of Sup’Biotech and furthermore laureates of the seventh Shaker class in 2020 and the first Gene.IO class in November 2021.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
STH develops innovative ingredients using a reliable and sustainable plant-production system. Our platform will be able to produce its first dermo-cosmetic ingredient with improved anti-inflammatory properties by 2024. The company will focus thereafter on pharmaceutical cannabinoids.

ACCOMPLISHMENTS / PARTNERSHIPS / HIGHLIGHTS
STH BIOTECH obtained a grant from Bourse French Tech Emergence to finance its research program and benefits also from the Bpifrance Deeptech program.

PARTNERSHIPS SOUGHT
Co-development partnerships
Financing

More information

Strengths:
Expertise in cannabis, strategic partnerships

Innovation assets:
Plant-based biotechnology, performance, standardization, environmental impact.

Genopole’s Companies

#Industrial Biotech

In the same field

The VERY Food Co

Activity of research, sale, production, distribution and marketing of all unregulated food and agri-food products.

Discover

Synovance

Synovance has developed a revolutionary synthetic genomics platform for the conception of robust industrial bioproduction strains.

Discover

Altar

Ginkgo Bioworks is a specialist in the conception and operation of automated fluidic continuous culture systems for adaptive laboratory evolution and the development of microbial strains for industry.

Discover

Yposkesi, an SK pharmteco Company

YposKesi is the first French company to develop and manufacture gene and cell therapy products for rare diseases.

Discover

WatchFrog

WatchFrog markets in vivo biotechnological solutions for environmental risk assessment and the evaluation of the therapeutic, toxic or pollutant potential of all types of chemical, cosmetic or pharmaceutical compounds.

Discover

PHARMING

Pharming specializes in the production of recombinant proteins in transgenic rabbit milk.

Discover

Global Bioenergies

Global Bioenergies is developing a process to convert renewable resources into hydrocarbons through fermentation.

Discover

Abolis Biotechnologies

Abolis develops custom-order microorganisms able to produce molecules of interest via fermentation for the health, nutrition, chemistry and cosmetics sectors.

Discover

View all >

With the support from